Intra-Cellular Therapies Inc Logo Image

Intra-Cellular Therapies Inc

Intra-Cellular Therapies Inc has reached its limit for report views.

Please check back to see if Intra-Cellular Therapies Inc has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

Most Recent Annual Report

2016 Annual Report and Form 10K

Intra-Cellular Therapies Inc

Intra-Cellular Therapies Inc does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



Archived Annual Reports

  • Intra-Cellular Therapies Inc
  • Intra-Cellular Therapies Inc
  • Intra-Cellular Therapies Inc

About Intra-Cellular Therapies Inc

Based in New York City, New York

Intra-Cellular Therapies, Inc., a biopharmaceutical company, discovers and develops small molecule drugs for the treatment of neuropsychiatric and neurologic disorders within the central nervous system (CNS). Its lead drug candidate is ITI-007, which is in phase III clinical development for the treatment of schizophrenia, behavioral disturbances in dementia, bipolar disorder, depression, and other neuropsychiatric and neurological disorders.

Ticker:
ITCI
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol